Erratum to “Primary signet ring cell carcinoma of the cervix: A case report with review of the literature” [Taiwan J Obstet Gynecol 58 (2019) 46–50]

Successful treatment with CPT-11 plus S-1 therapy in a patient with primary signet-ring cell carcinoma of the uterine cervix: A case report and literature review

“…Furthermore, two stage III patients received CCRT and two stage IV patients received systemic chemotherapy as initial therapies. In reports on chemotherapy, cisplatin plus etoposide [1], paclitaxel plus carboplatin [7], and paclitaxel plus cisplatin plus bevacizumab [14] therapies were used. The number of cases is small, and there is no high-evidence level therapy for primary signetring cell carcinoma of the uterine cervix.…”